118 related articles for article (PubMed ID: 24033834)
1. Ghrelin prevents the development of dermal fibrosis in bleomycin-induced scleroderma.
Koca SS; Ozgen M; Sarikaya M; Dagli F; Ustundag B; Isik A
Clin Exp Dermatol; 2014 Mar; 39(2):176-81. PubMed ID: 24033834
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.
Ozgen M; Koca SS; Dagli AF; Gundogdu B; Ustundag B; Isik A
Clin Exp Dermatol; 2012 Jan; 37(1):48-54. PubMed ID: 22182434
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of etanercept in bleomycin-induced experimental scleroderma.
Koca SS; Isik A; Ozercan IH; Ustundag B; Evren B; Metin K
Rheumatology (Oxford); 2008 Feb; 47(2):172-5. PubMed ID: 18174229
[TBL] [Abstract][Full Text] [Related]
4. Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma.
Oyucu Orhan S; Tektemur A; Gözel N; Özercan İH; Yolbaş S; Yıldırım A; Önalan E; Koca SS
Turk J Med Sci; 2018 Aug; 48(4):886-891. PubMed ID: 30121056
[TBL] [Abstract][Full Text] [Related]
5. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma.
Koca SS; Ozgen M; Dagli AF; Gozel N; Ozercan IH; Isik A
Adv Clin Exp Med; 2016; 25(2):249-53. PubMed ID: 27627557
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
Zhou CF; Yu JF; Zhang JX; Jiang T; Xu SH; Yu QY; Zhu QX
Clin Exp Dermatol; 2013 Jun; 38(4):403-9. PubMed ID: 23517443
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition prevents development of experimental dermal fibrosis.
Koca SS; Ozgen M; Dagli F; Tuzcu M; Ozercan IH; Sahin K; Isik A
Inflammation; 2012 Jun; 35(3):810-7. PubMed ID: 21882074
[TBL] [Abstract][Full Text] [Related]
8. Genistein protects dermal fibrosis in bleomycin-induced experimental scleroderma.
Koca SS; Dağlı AF; Yolbaş S; Gözel N; Işık A
Eur J Rheumatol; 2015 Sep; 2(3):99-102. PubMed ID: 27708939
[TBL] [Abstract][Full Text] [Related]
9. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
10. Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma.
Kitaba S; Murota H; Terao M; Azukizawa H; Terabe F; Shima Y; Fujimoto M; Tanaka T; Naka T; Kishimoto T; Katayama I
Am J Pathol; 2012 Jan; 180(1):165-76. PubMed ID: 22062222
[TBL] [Abstract][Full Text] [Related]
11. Effects of oligoelements Se, Zn, and Mn plus Lachesis muta venom in experimental scleroderma.
Crescenti EJ; Medina VA; Sambuco LA; Cremaschi GA; Genaro AM; Cricco GP; Martín GA; Valli E; Martinel Lamas DJ; Perazzo JC; Rivera ES; Bergoc RM
Biol Trace Elem Res; 2014 Feb; 157(2):138-46. PubMed ID: 24363240
[TBL] [Abstract][Full Text] [Related]
12. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
[TBL] [Abstract][Full Text] [Related]
13. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypical characterization of macrophages in rat bleomycin-induced scleroderma.
Juniantito V; Izawa T; Yuasa T; Ichikawa C; Yano R; Kuwamura M; Yamate J
Vet Pathol; 2013 Jan; 50(1):76-85. PubMed ID: 22700848
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K
Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
[TBL] [Abstract][Full Text] [Related]
16. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
17. Role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1-knockout mice.
Liu S; Kapoor M; Shi-wen X; Kennedy L; Denton CP; Glogauer M; Abraham DJ; Leask A
Arthritis Rheum; 2008 Jul; 58(7):2189-95. PubMed ID: 18576327
[TBL] [Abstract][Full Text] [Related]
18. Activation of pregnane X receptor inhibits experimental dermal fibrosis.
Beyer C; Skapenko A; Distler A; Dees C; Reichert H; Munoz L; Leipe J; Schulze-Koops H; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2013 Apr; 72(4):621-5. PubMed ID: 23291432
[TBL] [Abstract][Full Text] [Related]
19. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
20. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
